User:Cmurph05/Margaret Faul
This is not a Wikipedia article: It is an individual user's work-in-progress page, and may be incomplete and/or unreliable. For guidance on developing this draft, see Wikipedia:So you made a userspace draft. Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL |
Maugaret Faul new article content ...
Margaret Faul | |
---|---|
Born | |
Alma mater | |
Known for | Green Chemistry |
Scientific career | |
Fields | Chemistry |
Institutions | Amgen |
Doctoral advisor | Professor David A. Evans |
Margaret Faul is Vice President of Drug Product Technologies at Amgen Inc, in Thousand Oaks, CA. She is responsible to develop the commercial processes for modalities within the Amgen portfolio from preclinical to commercial.[1]
Thieme Chemistry and the Editors of Science of Synthesis announced the Dr. Margaret Faul Women in Chemistry Award Dr. Margaret Faul Women in Chemistry Award to be inaugurated in 2019.[2]
She is or has been on the editor board of: Science of Synthesis, Organic Synthesis, Journal of Organic Chemistry and Organic and Biomolecular Chemistry.
References
[edit]- ^ https://www.thieme.de/en/thieme-chemistry/portrait-of-dr-margaret-faul-135857.htm.
{{cite web}}
: Missing or empty|title=
(help) - ^ "Women in Chemistry Award - Thieme Chemistry - Georg Thieme Verlag KG". Thieme.